Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.42 AUD | -0.67% | -1.78% | -8.30% |
Apr. 30 | ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8% | MT |
Apr. 17 | Impedimed Implements Organizational Changes; Makes Strategy Chief, COO Redundant | MT |
Sales 2024 * | 297M 198M | Sales 2025 * | 398M 266M | Capitalization | 457M 306M |
---|---|---|---|---|---|
Net income 2024 * | 21M 14.04M | Net income 2025 * | 30M 20.06M | EV / Sales 2024 * | 1.6 x |
Net Debt 2024 * | 17.01M 11.37M | Net Debt 2025 * | 22.65M 15.15M | EV / Sales 2025 * | 1.2 x |
P/E ratio 2024 * |
24.1
x | P/E ratio 2025 * |
15
x | Employees | - |
Yield 2024 * |
2.32% | Yield 2025 * |
3.11% | Free-Float | 69.3% |
Latest transcript on IPD Group Limited
1 day | -0.67% | ||
1 week | -1.78% | ||
Current month | -3.49% | ||
1 month | -6.36% | ||
3 months | -14.34% | ||
6 months | +10.22% | ||
Current year | -8.30% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 14-12-31 | |
Jason Boschetti
DFI | Director of Finance/CFO | - | 22-11-27 |
Mohamed Yoosuff
PRN | Corporate Officer/Principal | - | 04-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Moffat
BRD | Director/Board Member | 62 | 20-03-23 |
David Rafter
CHM | Chairman | - | 19-08-13 |
Chief Executive Officer | - | 14-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 4.42 | -0.67% | 54 709 |
24-05-14 | 4.45 | +0.68% | 47,459 |
24-05-13 | 4.42 | +0.23% | 63,385 |
24-05-10 | 4.41 | -0.23% | 111,758 |
24-05-09 | 4.42 | -2.86% | 138,599 |
Delayed Quote Australian S.E., May 15, 2024 at 02:10 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.30% | 305M | |
+5.88% | 9.13B | |
+10.74% | 9.12B | |
+25.09% | 8.21B | |
+10.00% | 1.36B | |
+84.28% | 760M | |
-6.86% | 684M | |
+77.78% | 646M | |
-1.43% | 607M | |
+220.97% | 606M |
- Stock Market
- Equities
- IPG Stock